Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Receivables - Other (2016 - 2018)

Arcadia Biosciences filings provide 4 years of Receivables - Other readings, the most recent being $3000.0 for Q4 2018.

  • On a quarterly basis, Receivables - Other fell 25.0% to $3000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $3000.0, a 25.0% decrease, with the full-year FY2018 number at $3000.0, down 25.0% from a year prior.
  • Receivables - Other hit $3000.0 in Q4 2018 for Arcadia Biosciences, down from $168000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $184000.0 in Q4 2016 to a low of $3000.0 in Q4 2018.
  • Median Receivables - Other over the past 4 years was $94000.0 (2015), compared with a mean of $91000.0.
  • Biggest five-year swings in Receivables - Other: tumbled 97.83% in 2017 and later soared 175.41% in 2018.
  • Arcadia Biosciences' Receivables - Other stood at $82000.0 in 2015, then surged by 124.39% to $184000.0 in 2016, then tumbled by 97.83% to $4000.0 in 2017, then fell by 25.0% to $3000.0 in 2018.
  • The last three reported values for Receivables - Other were $3000.0 (Q4 2018), $168000.0 (Q3 2018), and $106000.0 (Q2 2018) per Business Quant data.